Active Ingredient(s): Tolazamide
FDA Approved: * July 18, 1966
Category: Diabetes

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".

Tolinase Overview

Tolazamide is an oral blood glucose lowering drug used for people with Type 2 diabetes. It is part of the sulfonylurea family (ATC A10BB). Synthesis Tolazemide synthesis:[1] U.S. Patent 3,063,903 .mw-parser-output .citation{word-wrap:break-word}.mw-parser-output .citation:target{background-color:rgba(0,127,255,0.133)}GB 887886 DE 1196200 para-Toluenesulfonamide is converted to its carbamate with ethyl chloroformate in the presence of a base. Heating that intermediate with...

Read more Tolinase Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source:

Recent Tolinase Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

  • Tablet: 100mg, 250mg, 500mg
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

NDC Database Records for Tolinase: (3 results)

Sorted by National Drug Code
  • 0009-0070 Tolinase 100 mg Oral Tablet by Pharmacia and Upjohn Company
  • 0009-0114 Tolinase 250 mg Oral Tablet by Pharmacia and Upjohn Company
  • 0009-0477 Tolinase 500 mg Oral Tablet by Pharmacia and Upjohn Company

Other drugs which contain Tolazamide or a similar ingredient: (1 result)